MedPath

prospective observational study for evaluating Efficacy and safety of Megaderm applied in autologous flap defect site in Breast reconstruction patient with conjoined fascial flap

Not Applicable
Recruiting
Conditions
Neoplasms
Registration Number
KCT0007650
Lead Sponsor
Kyungpook National University Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
20
Inclusion Criteria

? over 19 years of age
? Those patients who had undergone breast reconstruction with autologous flap after mastectomy due to breast cancer
? In case of ADM(megaderm) applied in a breast reconstruction surgery

Exclusion Criteria

? current smoker (over one cigarette in a day)
? patients confirmed whole body metastasis of breast cancer
? who will be get a radiation therapy after surgery
? who have been Angina pectoris, COPD, diabetes, renal failure, metabolic disease or any of history
? pregnant or lactating women

Study & Design

Study Type
Observational Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Aesthetic outcome;Evaluation of the frequency and rate of complication
Secondary Outcome Measures
NameTimeMethod
Evaluation of satisfaction
© Copyright 2025. All Rights Reserved by MedPath